Pregnancy outcomes in women with growth hormone deficiency
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10312191" target="_blank" >RIV/00216208:11110/15:10312191 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00064165:_____/15:10312191
Výsledek na webu
<a href="http://dx.doi.org/10.1016/j.fertnstert.2015.07.1132" target="_blank" >http://dx.doi.org/10.1016/j.fertnstert.2015.07.1132</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.fertnstert.2015.07.1132" target="_blank" >10.1016/j.fertnstert.2015.07.1132</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Pregnancy outcomes in women with growth hormone deficiency
Popis výsledku v původním jazyce
Objective: To study pregnancies in a large group of patients with growth hormone deficiency and hypopituitarism; and to investigate potential factors determining pregnancy outcomes and pregnancy complications. Design: We analyzed pregnancies reported inKIMS, the Pfizer International Metabolic Database, of adult patients with growth hormone deficiency treated with growth hormone. Setting: Outpatient clinics. Patient(s): A total of 201 pregnancies were reported: 173 in female patients and 28 in partnersof male patients. Intervention(s): Growth hormone replacement therapy (GHRT) was prescribed according to the local clinical practice. Main Outcome Measure(s): Pregnancy outcomes (live births, gestational week at delivery, and birth weight), pregnancy complications, and their relationship to use of GHRT during pregnancy were analyzed with regression models. Result(s): Two-thirds of women underwent fertility treatment to achieve pregnancy. Growth hormone replacement therapy was stopped bef
Název v anglickém jazyce
Pregnancy outcomes in women with growth hormone deficiency
Popis výsledku anglicky
Objective: To study pregnancies in a large group of patients with growth hormone deficiency and hypopituitarism; and to investigate potential factors determining pregnancy outcomes and pregnancy complications. Design: We analyzed pregnancies reported inKIMS, the Pfizer International Metabolic Database, of adult patients with growth hormone deficiency treated with growth hormone. Setting: Outpatient clinics. Patient(s): A total of 201 pregnancies were reported: 173 in female patients and 28 in partnersof male patients. Intervention(s): Growth hormone replacement therapy (GHRT) was prescribed according to the local clinical practice. Main Outcome Measure(s): Pregnancy outcomes (live births, gestational week at delivery, and birth weight), pregnancy complications, and their relationship to use of GHRT during pregnancy were analyzed with regression models. Result(s): Two-thirds of women underwent fertility treatment to achieve pregnancy. Growth hormone replacement therapy was stopped bef
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FB - Endokrinologie, diabetologie, metabolismus, výživa
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2015
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Fertility and Sterility
ISSN
0015-0282
e-ISSN
—
Svazek periodika
104
Číslo periodika v rámci svazku
5
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
8
Strana od-do
1210-1217
Kód UT WoS článku
000366486400028
EID výsledku v databázi Scopus
2-s2.0-84946471719